Perma-Fix Medical has successfully completed the scale-up of its process to produce technetium-99m (Tc-99m) from molybdenum.
The Polish subsidiary of Perma-Fix Environmental Services confirmed that its proprietary resin could withstand higher levels of radiation, up to 6 curies, and provide clinically useful doses of Tc-99m. The two tests included one run using natural molybdenum and a second run using enriched molybdenum-98 (Mo-98).
Perma-Fix Medical plans to conduct additional tests at these or higher curie levels in the near future as part of its process to validate its Tc-99m technology.
The company has developed a specialized resin that is radiation-resistant and holds large quantities of molybdenum, while also releasing nearly 90% of the Tc-99m as it forms from the decay of Mo-99.
